No Data
No Data
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
JMP Securities Maintains Bicycle Therapeutics(BCYC.US) With Buy Rating, Maintains Target Price $26
Morgan Stanley Maintains Bicycle Therapeutics(BCYC.US) With Hold Rating, Cuts Target Price to $15
A Quick Look at Today's Ratings for Bicycle Therapeutics(BCYC.US), With a Forecast Between $26 to $42
Bicycle Therapeutics Price Target Maintained With a $30.00/Share by Needham
Express News | Needham Reiterates Buy on Bicycle Therapeutics, Maintains $30 Price Target